Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,983    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,070,832      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,958 Incyte Corp $883,876 Immunome Inc. $112,702 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,958 Incyte Corp $883,876 Immunome Inc. $112,702
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 18 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-01 4 AS $35.00 $699,920 D/D (20,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2007-12-17 4 AS $35.15 $532,934 D/D (15,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-01-02 4 AS $35.28 $540,978 D/D (15,000) 7,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-02-23 4 S $35.31 $176,541 D/D (5,000) 121,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-02 4 AS $35.72 $357,200 D/D (10,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-07 4 AS $35.96 $179,800 D/D (5,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-01 4 AS $36.00 $275,069 D/D (7,453) 18,667 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-04 4 AS $36.00 $360,000 D/D (10,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-02-29 4 S $36.26 $36,258 D/D (1,000) 115,093 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-02 4 AS $36.50 $376,050 D/D (10,100) 8,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-08 4 AS $36.52 $547,800 D/D (15,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2008-05-05 4 AS $36.53 $182,729 D/D (5,000) 3,567 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2012-05-03 4 AS $36.68 $366,800 D/D (10,000) 113,191 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-04-30 4 OE $37.46 $37,460 D/D 1,000 303,498 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-06-21 4 OE $37.46 $37,460 D/D 1,000 304,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-10-20 4 OE $37.46 $37,460 D/D 1,000 305,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-15 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-12-16 4 OE $37.46 $224,760 D/D 6,000 309,689 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-12 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-01-13 4 OE $37.46 $187,300 D/D 5,000 308,789 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-10 4 OE $37.46 $561,900 D/D 15,000 353,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-11 4 OE $37.46 $561,900 D/D 15,000 353,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-14 4 OE $37.46 $374,600 D/D 10,000 344,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 OE $37.46 $749,200 D/D 20,000 354,983 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18  19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 18 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us